TrialNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2024

Rituximab or cyclosporine A for the treatment of membranous nephropathy: economic evaluation of the MENTOR trial.

Matthew Kadatz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.